Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Publications

Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.

Journal article

Kwon YN. et al, (2022), J Neurol

Frequency of MOG-IgG in cerebrospinal fluid versus serum

Journal article

Pace S. et al, (2021), Journal of Neurology, Neurosurgery and Psychiatry

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies

Journal article

McGinty R. et al, (2020), Journal of Neurology, Neurosurgery & Psychiatry

Prevalence of NMOSD and MS in the Indigenous Populations of Australia and New Zealand

Conference paper

Broadley SA. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP44 - NP44

Serum Cytokine Profiles of Myelin Oligodendrocyte Glycoprotein Encephalomyelitis

Conference paper

Kwon YN. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP88 - NP88

Cell-based assays for the detection of MOG antibodies: a comparative study.

Journal article

Gastaldi M. et al, (2020), J Neurol

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.

Journal article

Michael S. et al, (2020), Pract Neurol

Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.

Journal article

O'Connell K. et al, (2020), J Neurol Neurosurg Psychiatry

We need to talk about MOG.

Journal article

Waters P. and Palace J., (2020), Neurology

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.

Journal article

Ramberger M. et al, (2020), Brain, 143, 1731 - 1745

Cell-based assays for the detection of myelin oligodendrocyte glycoprotein antibodies: a single centre comparative study

Conference paper

Gastaldi M. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74

Development Of Silent Brain Lesions In Pediatric Patients With Antibodies To Myelin Oligodendrocyte Glycoprotein

Conference paper

Fadda G. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, 30 - 30

Immunological mechanisms for the efficacy of Rituximab in aquaporin-4 autoantibody mediated Neuromyelitis Optica spectrum disorders

Conference paper

Damato V. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74

International multicenter examination of MOG antibody assays (vol 7, e674, 2020)

Journal article

Reindl M. et al, (2020), NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 7

Real-world prevalence of autoantibodies in epilepsy

Conference paper

McGinty RN. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 61 - 61

Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases.

Journal article

Kim Y. et al, (2020), Mult Scler Relat Disord, 40

Bone health in neuromyelitis optica: Bone mineral density and fractures.

Journal article

Kwon YN. et al, (2020), Mult Scler Relat Disord, 42

Development of Silent Brain Lesions in Pediatric Patients with anti-MOG-Associated Demyelination

Conference paper

Fadda G. et al, (2020), NEUROLOGY, 94

International multicenter examination of MOG antibody assays.

Journal article

WATERS P., (2020), Neurology, Neuroimmunology and Neuroinflammation

The clinical profile of NMOSD in Australia and New Zealand.

Journal article

Bukhari W. et al, (2020), J Neurol

Load More